Stem‐Like Cells with Luminal Progenitor Phenotype Survive Castration in Human Prostate Cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Stem Cells

• Publication date

  2012-03-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/stem.1087PMID 22438320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroidogenic Enzymes and Stem Cell Markers Are Upregulated during Androgen Deprivation in Prostate Cancer

  2011cited by this paper
• Revisiting the concept of cancer stem cells in prostate cancer

  2011cited by this paper
• Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling

  2011cited by this paper
• Isolation, cultivation and characterization of adult murine prostate stem cells

  2010cited by this paper
• Stem cell characteristics in prostate cancer cell lines.

  2010cited by this paper
• Prioritizing genes associated with prostate cancer development

  2010cited by this paper
• High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer.

  2010cited by this paper
• Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells.

  2010cited by this paper
• Primitive origins of prostate cancer: In vivo evidence for prostate‐regenerating cells and prostate cancer‐initiating cells

  2010cited by this paper
• Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.

  2010cited by this paper
• Molecular genetics of prostate cancer: new prospects for old challenges.

  2010cited by this paper
• Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

  2009cited by this paper
• Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer.

  2009cited by this paper
• In vitro propagation and characterization of neoplastic stem/progenitor‐like cells from human prostate cancer tissue

  2009cited by this paper
• A luminal epithelial stem cell that is a cell of origin for prostate cancer

  2009cited by this paper
• ALDH1A1 Is a Marker for Malignant Prostate Stem Cells and Predictor of Prostate Cancer Patients’ Outcome

  2009cited by this paper
• Functional Evidence that the Self‐Renewal Gene NANOG Regulates Human Tumor Development

  2009cited by this paper
• Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer

  2009cited by this paper
• Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

  2009cited by this paper
• Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis.

  2009cited by this paper
• Regulation of Stem Cell Pluripotency and Differentiation Involves a Mutual Regulatory Circuit of the Nanog, OCT4, and SOX2 Pluripotency Transcription Factors With Polycomb Repressive Complexes and Stem Cell microRNAs

  2009cited by this paper
• Steroid hormone receptors in prostate cancer: a hard habit to break?

  2009cited by this paper
• Androgen deprivation and stem cell markers in prostate cancers.

  2009cited by this paper
• CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

  2008cited by this paper
• The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.

  2008cited by this paper
• The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells.

  2008cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• Androgen Regulation of Aldehyde Dehydrogenase 1A3 (ALDH1A3) in the Androgen-Responsive Human Prostate Cancer Cell Line LNCaP

  2007cited by this paper
• Hierarchical Organization of Prostate Cancer Cells in Xenograft Tumors: The CD44+α2β1+ Cell Population Is Enriched in Tumor-Initiating Cells

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.

  2007cited by this paper
• Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo.

  2007cited by this paper
• Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.

  2007cited by this paper
• Mechanisms Underlying the Development of Androgen-Independent Prostate Cancer

  2006cited by this paper
• Emergence of androgen independence at early stages of prostate cancer progression in Nkx3.1; Pten mice.

  2006cited by this paper
• Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

  2006cited by this paper
• Immunohistochemical characterization of neuroendocrine cells in prostate cancer

  2006cited by this paper
• Immortalization of primary human prostate epithelial cells by c-Myc.

  2005cited by this paper
• Prospective identification of tumorigenic prostate cancer stem cells.

  2005cited by this paper
• BM18: A novel androgen‐dependent human prostate cancer xenograft model derived from a bone metastasis

  2005cited by this paper
• Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities.

  2005cited by this paper
• A tumour stem cell hypothesis for the origins of prostate cancer

  2005cited by this paper
• Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

  2003cited by this paper
• The Current State of Hormonal Therapy for Prostate Cancer

  2002cited by this paper
• Proximal location of mouse prostate epithelial stem cells

  2002cited by this paper
• Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.

  2001cited by this paper
• Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma.

  1999cited by this paper
• Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo.

  1999cited by this paper
• Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process.

  1999cited by this paper
• Neuroendocrine cells in benign and malignant prostate tissue: Morphogenesis, proliferation, and androgen receptor status

  1998cited by this paper
• Stem Cell Genes in Androgen-independent Prostate Cancer

  1998cited by this paper
• Development of seven new human prostate tumor xenograft models and their histopathological characterization.

  1996cited by this paper
• Neuroendocrine differentiation in human prostatic tumor models.

  1996cited by this paper
• Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors.

  1995cited by this paper
• Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.

  1990cited by this paper
• Etiology and disease process of benign prostatic hyperplasia

  1989cited by this paper
• Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement

  1987cited by this paper
• Identification in histological sections of species origin of cells from mouse, rat and human.

  1984cited by this paper
• Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma.

  1981cited by this paper

• A modular patient-derived organoid–xenograft platform reveals molecular and clinical trajectories of prostate cancer progression

  2026cites this paper
• ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development

  2025cites this paper
• Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review)

  2025influential citation
• Klf5-adjacent super-enhancer functions as a 3D genome structure-dependent transcriptional driver to safeguard ESC identity

  2025cites this paper
• Current uses and resistance mechanisms of enzalutamide in prostate cancer treatment

  2024cites this paper
• Everything you ever wanted to know about cancer stem cells in neuroendocrine neoplasms but were afraid to ask

  2024cites this paper
• IMPA1-derived inositol maintains stemness in castration-resistant prostate cancer via IMPDH2 activation

  2024cites this paper
• Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance

  2024cites this paper
• Prostate cancer stem cells and their targeted therapies

  2024cites this paper
• Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression

  2024cites this paper
• Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model

  2023cites this paper
• Therapeutic implications of cancer stem cells in prostate cancer

  2023cites this paper
• Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p‐STAT3 in prostate cancer

  2023cites this paper
• Cancer stem cell in prostate cancer progression, metastasis and therapy resistance.

  2023cites this paper
• The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity

  2022cites this paper
• Circulating tumor cells and DNAs in prostate tumors

  2022cites this paper
• Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy

  2022cites this paper
• Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones

  2022cites this paper
• Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen

  2022cites this paper
• The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications

  2022cites this paper
• Understanding and targeting prostate cancer cell heterogeneity and plasticity

  2021cites this paper
• The Role of Nkx3.1 in Cancers and Stemness

  2021cites this paper
• Decoding the heterogeneous landscape in the development prostate cancer

  2021cites this paper
• Per- and Polyfluoroalkyl Substances Target and Alter Human Prostate Stem-Progenitor Cells.

  2021cites this paper
• Hallmarks of cancer stem cells in men associated cancers: a review

  2020cites this paper
• PreImplantation Factor immunohistochemical expression correlates with prostate cancer aggressiveness

  2020cites this paper
• Patterns of stemness-associated markers in the development of castration-resistant prostate cancer.

  2020cites this paper
• The Effect of Bowman-Birk Inhibitor from Soybeans on the Sensitivity of Prostate Cancer Stem-like Cells to Anti-androgen Agent

  2020cites this paper
• Isolation and Characterization of Prostate Cancer Stem cells from Prostate Cancer Tissues

  2020cites this paper
• Zebrafish Microenvironment Elevates EMT and CSC-Like Phenotype of Engrafted Prostate Cancer Cells

  2020cites this paper
• CMAR_A_190678 2747..2758

  2019cites this paper
• Crosstalk Between Prostate Cancer Stem Cells and Immune Cells: Implications for Tumor Progression and Resistance to Immunotherapy

  2019cites this paper
• Chromogranin A is a predictor of prognosis in patients with prostate cancer: a systematic review and meta-analysis

  2019cites this paper
• Cells of Origin for Prostate Cancer.

  2019cites this paper
• Mechanisms of Prostate Cancer Bone Metastasis

  2019cites this paper
• Metastases in Prostate Cancer.

  2019cites this paper
• Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer

  2019cites this paper
• Cellular plasticity and the neuroendocrine phenotype in prostate cancer

  2018cites this paper
• Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation

  2018cites this paper
• Prostate Luminal Progenitor Cells in Development and Cancer.

  2018cites this paper
• The prostatic cellular and molecular kaleidoscope. Starting points for carcinogenesis.

  2018cites this paper
• EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers.

  2018cites this paper
• Prognostic role of chromogranin A in castration-resistant prostate cancer: a meta-analysis

  2018cites this paper
• Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis

  2017cites this paper
• ANDROGEN RECEPTOR AND PROSTATE CANCER CELL HETEROGENEITY

  2017cites this paper
• Stem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium.

  2017cites this paper
• Label retention and stem cell marker expression in the developing and adult prostate identifies basal and luminal epithelial stem cell subpopulations

  2017cites this paper
• Patient-Derived Xenograft Models of Prostate Tumors

  2017cites this paper
• Genetically engineered oncolytic Newcastle disease virus mediates cytolysis of prostate cancer stem like cells.

  2017cites this paper
• ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models

  2017influential citation
• A Prominent Couple : the TMPRSS2:ERG Gene Fusion in Aggressive Prostate Cancer

  2017influential citation
• Class I HDAC inhibitor mocetinostat induces apoptosis by activation of miR-31 expression and suppression of E2F6

  2016cites this paper
• Stem Cells and Cancer

  2016cites this paper
• Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer

  2016cites this paper
• The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem Cells

  2016cites this paper
• Linneg Sca-1high CD49fhigh prostate cancer cells derived from the Hi-Myc mouse model are tumor-initiating cells with basal-epithelial characteristics and differentiation potential in vitro and in vivo

  2016cites this paper
• Biology of Bone Metastases in Prostate Cancer.

  2016cites this paper
• Tumors De fi ning a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer

  2016cites this paper
• The molecular and cellular origin of human prostate cancer.

  2016cites this paper
• In memoriam: Marco G Cecchini, 1951–2016

  2016cites this paper
• Maintaining a Healthy Balance: Targeting TERT to Stem Benign Prostatic Hyperplasia.

  2016cites this paper
• Prostate cancer stem cells : potential new biomarkers

  2016cites this paper
• The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges

  2016cites this paper
• AWARD NUMBER: W81XWH-12-1-0132 TITLE: CpG-STAT3siRNA for Castration-Resistant Prostate Cancer Therapy

  2015cites this paper
• The many ways to make a luminal cell and a prostate cancer cell.

  2015cites this paper
• Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.

  2015cites this paper
• TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells

  2015cites this paper
• Stat5a/b in Prostate Cancer Metastasis.

  2015cites this paper
• Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions

  2015cites this paper
• Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling

  2015cites this paper
• Regulation of tumor cell plasticity by the androgen receptor in prostate cancer.

  2015cites this paper
• Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?

  2015influential citation
• Mitotic quiescence, but not unique “stemness,” marks the phenotype of bone metastasis‐initiating cells in prostate cancer

  2015cites this paper
• Stem cells in genetically-engineered mouse models of prostate cancer.

  2015influential citation
• Biology of Human Tumors ExpressionofAndrogenandEstrogenSignalingComponents and Stem Cell Markers to Predict Cancer Progression and Cancer-Speci fi cSurvival in PatientswithMetastatic Prostate Cancer

  2015influential citation
• Erratum to: Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling

  2015cites this paper
• Insights into Chemoresistance of Prostate Cancer

  2015cites this paper
• Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer

  2015influential citation
• Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles

  2015cites this paper
• Expression of Androgen and Estrogen Signaling Components and Stem Cell Markers to Predict Cancer Progression and Cancer-Specific Survival in Patients with Metastatic Prostate Cancer

  2014influential citation
• Concise Reviews: Cancer Stem Cells: From Concept to Cure

  2014cites this paper
• Androgen Receptor Increases CD133 Expression and Progenitor-Like Population That Associate With Cisplatin Resistance in Endometrial Cancer Cell Line

  2014cites this paper
• Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide

  2014cites this paper
• Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategies.

  2014cites this paper
• Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis

  2014influential citation
• Prostate Cancer Stem Cells: A Brief Review

  2013cites this paper
• Genetically engineered mouse models of prostate cancer

  2013cites this paper
• The molecular basis for ethnic variation and histological subtype differences in prostate cancer

  2013cites this paper
• Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1

  2013cites this paper
• Adaptation and clonal selection models of castration‐resistant prostate cancer: Current perspective

  2013cites this paper
• Cancer stem cells in prostate cancer

  2013cites this paper
• Functional activation of ATM by the prostate cancer suppressor NKX3.1.

  2013cites this paper
• Dissociated Primary Human Prostate Cancer Cells Coinjected with the Immortalized Hs5 Bone Marrow Stromal Cells Generate Undifferentiated Tumors in NOD/SCID-γ Mice

  2013cites this paper
• Stem Cells and Prostate Cancer

  2013cites this paper
• Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancer

  2013cites this paper
• Induced Pluripotency of Human Prostatic Epithelial Cells

  2013cites this paper
• QChIPat: a quantitative method to identify distinct binding patterns for two biological ChIP-seq samples in different experimental conditions

  2013cites this paper
• Phosphorylation of Nanog is Essential to Regulate Bmi1 and Promote Tumorigenesis

  2013cites this paper
• Searching for Prostate Cancer Stem Cells: Markers and Methods

  2013influential citation
• Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer

  2013cites this paper